Cargando…
The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry
BACKGROUND: Rare peritoneal cancers represent complex clinical situations requiring a specific and multidisciplinary management. Because of their rarity, lack of awareness and knowledge often leads to diagnostic delays and misdiagnosis. And patients are not systematically referred to expert centers...
Autores principales: | Villeneuve, L., Passot, G., Glehen, O., Isaac, S., Bibeau, F., Rousset, P., Gilly, F. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316145/ https://www.ncbi.nlm.nih.gov/pubmed/28212684 http://dx.doi.org/10.1186/s13023-017-0571-y |
Ejemplares similares
-
Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups
por: Glehen, O., et al.
Publicado: (2020) -
Prise en charge des tumeurs primitives et métastatiques du péritoine en période de pandémie CoViD-19. Pistes de réflexion et de priorisation du groupe RENAPE et BIG-RENAPE()
por: Glehen, O., et al.
Publicado: (2020) -
Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric Study
por: Dumont, Frédéric, et al.
Publicado: (2023) -
Establishing Patient Registries for Rare Diseases: Rationale and Challenges
por: Boulanger, Vanessa, et al.
Publicado: (2020) -
Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups
por: Gomes David, Manuel, et al.
Publicado: (2022)